Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
A Phase I Trial of Ipilimumab (IPI) in Patients (PTS) with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent (HMAS) FailureZeidan, A ; Knaus, H ; Robinson, T ; Zeidner, J ; Blackford, A ; Duffield, A ; Rizzieri, D ; Frattini, M ; Levy, M.Y ; Schroeder, M ; Ferguson, A ; Sheldon, K ; Dezern, A ; Gojo, I ; Gore, S ; Streicher, H ; Luznik, L ; Smith, B.DLeukemia research, 2017-04, Vol.55, p.S43-S43 [Periódico revisado por pares]Texto completo disponível |
|
2 |
Material Type: Artigo
|
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I studyGoldberg, Aaron D. ; Atallah, Ehab ; Rizzieri, David ; Walter, Roland B. ; Chung, Ki-Young ; Spira, Alexander ; Stock, Wendy ; Tallman, Martin S. ; Cruz, Hans G. ; Boni, Joseph ; Havenith, Karin E.G. ; Chao, Grace ; Feingold, Jay M. ; Wuerthner, Jens ; Solh, MelhemLeukemia research, 2020-08, Vol.95, p.106385, Article 106385 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
64 - A Phase I Trial of Ipilimumab (IPI) in Patients (PTS) with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent (HMAS) FailureZeidan, A. ; Knaus, H. ; Robinson, T. ; Zeidner, J. ; Blackford, A. ; Duffield, A. ; Rizzieri, D. ; Frattini, M. ; Levy, M.Y. ; Schroeder, M. ; Ferguson, A. ; Sheldon, K. ; Dezern, A. ; Gojo, I. ; Gore, S. ; Streicher, H. ; Luznik, L. ; Smith, B.D.Leukemia research, 2017-04, Vol.55, p.S43-S43 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemiaMorris, Tod A ; DeCastro, Carlos M ; Diehl, Louis F ; Gockerman, Jon P ; Lagoo, Anand S ; Li, Zhiguo ; Moore, Joseph O ; Rizzieri, David A ; Rao, Arati VLeukemia research, 2013-01, Vol.37 (1), p.28-31 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
5 |
Material Type: Artigo
|
Elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemiaGiles, Francis ; Rizzieri, David ; Ravandi, Farhad ; Swords, Ronan ; Jacobsen, Tove Flem ; O’Brien, SusanLeukemia research, 2012-04, Vol.36 (4), p.e71-e73 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromesde Castro, C ; Adams, D ; Rizzieri, D ; Moore, J ; Gockerman, J ; Diehl, L ; Horwitz, M ; Edmonds, E ; Warzecho, JLeukemia research, 2009-05, Vol.33, p.S137-S137 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
P129 A pilot study of decitabine in combination with arsenic trioxide for patients with myelodysplastic syndromesde Castro, C ; Adams, D ; Rizzieri, D ; Moore, J ; Gockerman, J ; Diehl, L ; Horwitz, M ; Edmonds, E ; Warzecho, JLeukemia research, 2009-05, Vol.33, p.S134-S134 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemiaLaughlin, Mary J. ; Rizzieri, David A. ; Smith, Clayton A. ; Moore, Joseph O. ; Lilly, Scott ; McGaughey, Dean ; Martin, P. ; Carrier, Carmellita ; Stevens, Cladd E. ; Rubinstein, Pablo ; Buckley, Rebecca ; Kurtzberg, JoanneLeukemia research, 1998-03, Vol.22 (3), p.215-219 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat diseaseGuerrero-Garcia, Thomas A. ; Mogollon, Renzo J. ; Castillo, Jorge J.Leukemia research, 2017-11, Vol.62, p.12-16 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
Outcomes of fludarabine, high dose cytarabine and granulocyte-colony stimulating factor (FLAG) as re-induction for residual acute myeloid leukemia on day 14 bone marrowJamy, Omer ; Bae, Sejong ; Costa, Luciano J. ; Erba, Harry P. ; Papadantonakis, NikolaosLeukemia research, 2018-11, Vol.74, p.64-67 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |